anonymous
Guest
anonymous
Guest
There’s a lot of buzz around S+N right now. Could a major acquisition be in the works? Nothing confirmed, but definitely something to keep an eye on.
Market cap at 12 billion fyi. Stryker market cap almost 140 billion and they have over 5 billion cash on hand. There’s a lot that can happen, especially if they are looking for production facilities world wide over our actual products…. Be easy to sell off a few divisions for them and keep what they want. Just saying, careful as SN is in desperation mode. 12 point 3 year plan coming to an end this year, and the way it looks they wanna blame it all on sales force for the way things turned out. The way SN has divisions segmented and separate it’s like they are begging for a sale and a scalp. No wonder why investors think shenanigans are at play.No one has 17Billion or would want 10 different divisions that don’t talk to one another.
Hopefully we sell to arthrex. My surgeons will jump ship with me so fast to wherever I want to go it will be awesome. Arthrex will watch half the SN Sales team leave with their surgeons, would be brutal to watch whoever tries to play with fire here.Likely :
Arthrex or Globus buys ortho divsion
Remaining 2 divisions left to go it alone but will be rough road. Ask linvatec how hard it is being a stand alone sport company.
The whole reason SN is in this position is because Ortho reps have been donkeys losing double digit share, so nice threatHopefully we sell to arthrex. My surgeons will jump ship with me so fast to wherever I want to go it will be awesome. Arthrex will watch half the SN Sales team leave with their surgeons, would be brutal to watch whoever tries to play with fire here.
You can’t even get us implants and instruments surgeons want to use. The jokes on management here. How poorly can you manage things, or……. Like investors are crying outloud currently the books have been cooked and it’s known to short sellers and those alike. Only so many years you can cook the books before it catches up to you. Welcome to smith and Nephew current issue, so obvious the CEO had to go on TV to try and defend the accusations but utterly failed at doing that. The cat is out of the bag at this point, the algorithms have targeted SN. 100,000,000,000% on leadership.The whole reason SN is in this position is because Ortho reps have been donkeys losing double digit share, so nice threat
Applied Medical will be acquiring SN. Perfect integration of products.There’s a lot of buzz around S+N right now. Could a major acquisition be in the works? Nothing confirmed, but definitely something to keep an eye on.